title: Transplantation of A2 kidneys into B and O recipients leads to reduction in waiting time: USRDS experience.
abstract: BACKGROUND
  Strategy of transplanting kidneys from A2 donors into patients with blood group B and O recipients has been used to alleviate the long waiting times.
  
  
  METHODS
  We used an inception cohort of US Renal Data System data base with patients older than 18 years who underwent renal transplantation between January 1995 and July 2006. The primary outcome variable was allograft loss (including death). Bivariate analysis of factors associated with receiving A2 or A2B kidneys was performed with chi-square testing for categorical variables (Fisher's exact test used for violations of Cochran's assumptions) and Student's t test for continuous variables (Mann-Whitney U test used for nonnormally distributed variables).
  
  
  RESULTS
  There were 150,118 first kidney transplants of whom 113 received kidney transplant from A2 to O, and 125 patients received A2 to B kidney transplant. Compared with other recipients from the same blood group, recipients of A2 kidneys had significantly shorter wait times. O recipients had a median wait time of 1.63 years (range 0.00-17.21 years), whereas O recipients who received A2 kidneys had a median wait time of 0.70 years (range 0.02-1.47 years; P<0.001). B recipients had a median wait time of 1.90 years (range 0.00-17.52 years), whereas B recipients who received A2 kidneys had a median wait time of 0.74 years (range 0.10-5.21 years; P<0.001). There was no significant difference in graft loss or death between A2 to O and B versus all other recipients.
  
  
  CONCLUSIONS
  The results showed that comparatively few patients received A2 to B or O kidney transplant.
authors.affiliation: Department of Nephrology, Walter Reed AMC, Washington, DC 20307, USA.
authors.forename: Frank P
authors.initials: FP
authors.lastname: Hurst
authors.forename: Imran
authors.initials: I
authors.lastname: Sajjad
authors.forename: Eric A
authors.initials: EA
authors.lastname: Elster
authors.forename: Edward M
authors.initials: EM
authors.lastname: Falta
authors.forename: Prem
authors.initials: P
authors.lastname: Patel
authors.forename: Kevin C
authors.initials: KC
authors.lastname: Abbott
authors.forename: Lawrence Y
authors.initials: LY
authors.lastname: Agodoa
authors.forename: Rahul M
authors.initials: RM
authors.lastname: Jindal
mesh_terms: D000017:ABO Blood-Group System; D000328:Adult; D001787:Blood Group Incompatibility; D002102:Cadaver; D015331:Cohort Studies; D016208:Databases, Factual; D003710:Demography; D006801:Humans; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000706:statistics & numerical data*; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D017582:Renal Replacement Therapy / Q000706:statistics & numerical data; D013997:Time Factors; D014019:Tissue Donors; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D014481:United States; D014850:Waiting Lists; D055815:Young Adult
chemical_list: D000017:ABO Blood-Group System